ArticleMolecular oncology2013

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.

Mads H Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.